Home

μαρούλι αριθμομηχανή Επικύρωση ioannis zerdes Κερδίζω εκχύλισμα Τυφλός

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för  forskning inom bröstcancer - Onkologi i Sverige
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer - Onkologi i Sverige

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

Ioannis Zerdes m diplom | Pfizer Sverige
Ioannis Zerdes m diplom | Pfizer Sverige

Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för  forskning inom bröstcancer
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer

Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein  and RNA Levels in Early Breast Cancer
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Alexios Matikas on LinkedIn: Ioannis Zerdes får nytt stipendium för sin  bröstcancerforskning | 16 comments
Alexios Matikas on LinkedIn: Ioannis Zerdes får nytt stipendium för sin bröstcancerforskning | 16 comments

Interplay between copy number alterations and immune profiles in the early  breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial:  results from a feasibility study | npj Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer

Ioannis Zerdes - Civil Engineer - Self-employed engineering, management &  grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn

The interplay between eosinophils and T cells in breast cancer  immunotherapy - Zerdes - 2023 - Molecular Oncology - Wiley Online Library
The interplay between eosinophils and T cells in breast cancer immunotherapy - Zerdes - 2023 - Molecular Oncology - Wiley Online Library

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Interplay between copy number alterations and immune profiles in the early  breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial:  results from a feasibility study | npj Breast Cancer
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer

Ioannis Zerdes - Customer Care Representative - Medtronic | LinkedIn
Ioannis Zerdes - Customer Care Representative - Medtronic | LinkedIn

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile

Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för  forskning inom bröstcancer
Maria Ekholm och Ioannis Zerdes tilldelas nytt onkologistipendium för forskning inom bröstcancer

Loop | Ioannis Zerdes
Loop | Ioannis Zerdes

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

Ioannis Zerdes - Oncology Resident - Karolinska University Hospital |  LinkedIn
Ioannis Zerdes - Oncology Resident - Karolinska University Hospital | LinkedIn

De är först att få nytt stipendium för cancerforskning
De är först att få nytt stipendium för cancerforskning

Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future  Holds for Breast Cancer Immunotherapy
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy

Jonas Bergh's Group | Karolinska Institutet
Jonas Bergh's Group | Karolinska Institutet

De är först att få nytt stipendium för cancerforskning
De är först att få nytt stipendium för cancerforskning

Ioannis Zerdes - Civil Engineer - Self-employed engineering, management &  grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn

Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology |  MD PhD | Karolinska Institutet, Solna | KI | Department of  Oncology-Pathology | Research profile
Ioannis ZERDES | Postdoctoral Researcher / Resident in Medical Oncology | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology | Research profile